NKF to welcome new chairman on April 15
Sign up now: Get ST's newsletters delivered to your inbox
Mr Ang Hao Yao (left) will take over from Mr Arthur Lang, who has served nearly five years in the role.
PHOTOS: THE NATIONAL KIDNEY FOUNDATION
Follow topic:
SINGAPORE – The National Kidney Foundation (NKF) will welcome a new chairman on April 15.
In a media statement on April 15, the NKF said Mr Ang Hao Yao will take over from Mr Arthur Lang, who has served nearly five years in the role.
Mr Ang, 52, joined the board of NKF in 2021 and served as its vice-chairman, as well as chairman of the tender and finance committee.
NKF said that Mr Ang was a veteran of the charity sector and brings extensive experience from leading and serving in numerous charity organisations. He is also currently the chairman of Credit Counselling Singapore and a former chairman of Sata CommHealth.
“Our focus must be on accelerating early intervention, expanding prevention efforts, and driving innovation in treatment. By doing so, we can enhance patient outcomes and create a more sustainable healthcare system for Singapore,” said Mr Ang.
Mr Lang, 53, will be stepping down after 10 years on the board. He joined NKF as a board director in 2015, and was appointed as chairman in November 2020
Under his leadership, NKF expanded its dialysis network
Mr Lang also pioneered the integration of dialysis centres with community and hospital facilities such as in Toa Payoh West Community Club, Yishun Community Hospital and Sengkang Community Hospital.
“During my time as board member and subsequently chairman, I have witnessed the unrelenting passion of the management, staff, caregivers and nurses of the NKF and I am truly honoured to have been part of this great team,” said Mr Lang.
He also welcomed Mr Ang as his successor, saying: “I am confident that under Hao Yao’s leadership, NKF will continue to break new ground in tackling kidney disease and supporting those in need.”
NKF is also investing $5.5 million in research and innovation as part of its Future Forward 2030 strategy. It aims to advance early detection and intervention, develop new renal replacement therapies and enhance psychosocial support for patients and caregivers.
The fund will also receive a dollar-to-dollar matching grant from the government – bringing the total to more than $10 million.
It is also scaling up preventative care and expanding its research collaborations with institutions including Singapore General Hospital, Singapore Polytechnic, National University of Singapore and general practitioner clinics
